Decay-accelerating factor in the periovulatory rat ovary

Journal of Endocrinology

Volumn 186, Issue 2, 2005, Pages 303-313

  Gieske, Mary C ^a   Na, Gi Youn ^c   Koo, Yongbum ^c   Jo, Misung ^b   Curry Jr , Thomas E ^b   Ko, Chemyong ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c Inje University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGESTAGEN; CHORIONIC GONADOTROPIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; DECAY ACCELERATING FACTOR; GLYCOSYLPHOSPHATIDYLINOSITOL; GONADOTROPIN; INDOMETACIN; MESSENGER RNA; MIFEPRISTONE; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CULTURE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; GENE EXPRESSION; HOST CELL; IN SITU HYBRIDIZATION; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; OVARY FOLLICLE; OVULATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTECTION; RAT; THECA CELL;

ANIMALS; ANTIGENS, CD55; BLOTTING, NORTHERN; CHORIONIC GONADOTROPIN; CYCLOOXYGENASE INHIBITORS; FEMALE; INDOMETHACIN; MIFEPRISTONE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OVULATION; PROGESTINS; PROTEIN ISOFORMS; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STIMULATION, CHEMICAL; THECA CELLS;

EID: 23844454491     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.1.06218     Document Type: Article

References (38)

1. Ahmad SR, Lidington EA, Ohta R, Okada N, Robson MG, Davies KA, Leitges M, Harris CL, Haskard DO & Mason JC 2003 Decay-accelerating factor induction by tumour necrosis factor-alpha, through a phosphatidylinositol-3 kinase and protein kinase C-dependent pathway, protects murine vascular endothelial cells against complement deposition. Immunology 110 258-268.
2. Brannstrom M & Enskog A 2002 Leukocyte networks and ovulation. Journal of Reproductive Immunology 57 47-60.
3. Cole DS & Morgan BP 2003 Beyond lysis: how complement influences cell fate. Clinical Science (London) 104 455-466.
4. Curry TE Jr & Osteen KG 2003 The matrix metalloproteinase system: changes, regulation, and impact throughout the ovarian and uterine reproductive cycle. Endocrine Reviews 24 428-465.
5. Espey LL 1980 Ovulation as an inflammatory reaction - a hypothesis. Biology of Reproduction 22 73-106.
6. Harris CL, Rushmere NK & Morgan BP 1999 Molecular and functional analysis of mouse decay accelerating factor (CD55). Biochemical Journal 341 821-829.
7. Hinchliffe SJ, Spiller OB, Rushmere NK & Morgan BP 1998 Molecular cloning and functional characterization of the rat analogue of human decay-accelerating factor (CD55). Journal of Immunology 161 5695-5703.
8. Hourcade D, Liszewski MK, Krych-Goldberg M & Atkinson JP 2000 Functional domains, structural variations and pathogen interactions of MCP, DAF and CR1. Immunopharmacology 49 103-116.
9. Jo M, Gieske MC, Payne CE, Wheeler-Price SE, Gieske JB, Ignatius IV, Curry TE Jr & Ko C 2004 Development and application of a rat ovarian gene expression database. Endocrinology 145 5384-5396.
10. Ko C & Park-Sarge OK 2000 Progesterone receptor activation mediates LH-induced type-I pituitary adenylate cyclase activating polypeptide receptor (PAC(1)) gene expression in rat granulosa cells. Biochemical and Biophysical Research Communications 277 270-279.
11. Ko C, In YH & Park-Sarge OK 1999 Role of progesterone receptor activation in pituitary adenylate cyclase activating polypeptide gene expression in rat ovary. Endocrinology 140 5185-5194.
12. Ko C, Grieshaber NA, Ji I & Ji TH 2003 Follicle-stimulating hormone suppresses cytosolic 3,5,3′-triiodothyronine-binding protein messenger ribonucleic acid expression in rat granulosa cells. Endocrinology 144 2360-2367.
13. Kuby J 1997 Immunology. New York: WH Freeman and Company.
14. Kumar S, Vinci JM, Pytel BA & Baglioni C 1993 Expression of messenger RNAs for complement inhibitors in human tissues and tumors. Cancer Research 53 348-353.
15. Lin F, Fukuoka Y, Spicer A, Ohta R, Okada N, Harris CL, Emancipator SN & Medof ME 2001 Tissue distribution of products of the mouse decay-accelerating factor (DAF) genes. Exploitation of a Daf1 knock-out mouse and site-specific monoclonal antibodies. Immunology 104 215-225.
16. Liszewski MK, Farries TC, Lublin DM, Rooney IA & Atkinson JP 1996 Control of the complement system. Advances in Immunology 61 201-283.
17. Magoffin DA & Erickson GF 1988 Purification of ovarian theca-interstitial cells by density gradient centrifugation. Endocrinology 122 2345-2347.
18. Mead R, Hinchliffe SJ & Morgan BP 1999 Molecular cloning, expression and characterization of the rat analogue of human membrane cofactor protein (MCP/CD46). Immunology 98 137-143.
19. Miwa T & Song WC 2001 Membrane complement regulatory proteins: insight from annual studies and relevance to human diseases. International Immunopharmacology 1 445-459.
20. Miwa T, Okada N & Okada H 2000 Alternative exon usage in the 3′ region of a single gene generates glycosylphosphatidylinositol-anchored and transmembrane forms of rat decay-accelerating factor. Immunogenetics 51 129-137.
21. Miwa T, Sun X, Ohta R, Okada N, Harris CL, Morgan BP & Song WC 2001 Characterization of glycosylphosphatidylinositol-anchored decay accelerating factor (GPI-DAF) and transmembrane DAF gene expression in wild-type and GPI-DAF gene knockout mice using polyclonal and monoclonal antibodies with dual or single specificity. Immunology 104 207-214.
22. Nauta AJ, Roos A & Daha MR 2004 A regulatory role for complement in innate immunity and autoimmunity. International Archives of Allergy and Immunology 134 310-323.
23. Ness RB, Grisso JA, Cottreau C, Klapper J, Vergona R, Wheeler JE, Morgan M & Schlesselman JJ 2000 Factors related to inflammation of the ovarian epithelium and risk of ovarian cancer. Epidemiology 11 111-117.
24. Norman RJ & Brannstrom M 1996 Cytokines in the ovary: pathophysiology and potential for pharmacological intervention. Pharmacology and Therapeutics 69 219-236.
25. Oglesby TJ, Longwith JE & Huettner PC 1996 Human complement regulator expression by the normal female reproductive tract. Anatomical Record 246 78-86.
26. Perricone R, de Carolis C, Moretti C, Santuari E, de Sanctis G & Fontana L 1990 Complement, complement activation and anaphylatoxins in human ovarian follicular fluid. Clinical and Experimental Immunology 82 359-362.
27. Perricone R, Pasetto N, De Carolis C, Vaquero E, Noccioli G, Panerai AE & Fontana L 1992 Cystic ovaries in women affected with hereditary angioedema. Clinical and Experimental Immunology 90 401-404.
28. Perricone R, De Carolis C, Giacomello F, Giacomelli R, De Sanctis G & Fontana L 2000 Impaired human ovarian follicular fluid complement function in hereditary angioedema. Scandinavian Journal of Immunology 51 104-108.
29. Richards JS, Russell DL, Robker RL, Dajee M & Alliston TN 1998 Molecular mechanisms of ovulation and luteinization. Molecular and Cellular Endocrinology 145 47-54.
30. Richards JS, Russell DL, Ochsner S & Espey LL 2002 Ovulation: new dimensions and new regulators of the inflammatory-like response. Annual Review of Physiology 64 69-92.
31. Robker RL, Russell DL, Espey LL, Lydon JP, O'Malley BW & Richards JS 2000 Progesterone-regulated genes in the ovulation process: ADAMTS-1 and cathepsin L proteases. PNAS 97 4689-4694.
32. Runesson E, Ivarsson K, Janson PO & Brannstrom M 2000 Gonadotropin- and cytokine-regulated expression of the chemokine interleukin 8 in the human preovulatory follicle of the menstrual cycle. Journal of Clinical Endocrinology and Metabolism 85 4387-4395.
33. Sasson R, Dantes A, Tajima K & Amsterdam A 2003 Novel genes modulated by FSH in normal and immortalized FSH-responsive cells: new insights into the mechanism of FSH action. FASEB Journal 17 1256-1266.
34. Spiller OB, Hanna SM & Morgan BP 1999 Tissue distribution of the rat analogue of decay-accelerating factor. Immunology 97 374-384.
35. Sun X, Funk CD, Deng C, Sahu A, Lambris JD & Song WC 1999 Role of decay-accelerating factor in regulating complement activation on the erythrocyte surface as revealed by gene targeting. PNAS 96 628-633.
36. Ushigoe K, Irahara M, Fukumochi M, Kamada M & Aono T 2000 Production and regulation of cytokine-induced neutrophil chemoattractant in rat ovulation. Biology of Reproduction 63 121-126.
37. Walport MJ 2001 Complement. First of two parts. New England Journal of Medicine 344 1058-1066.
38. Wong KH, Negishi H & Adashi EY 2002 Expression, hormonal regulation, and cyclic variation of chemokines in the rat ovary: key determinants of the intraovarian residence of representatives of the white blood cell series. Endocrinology 143 784-791.